Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David S Macdonald
TRU
David S Macdonald
Truist Financial
Wall Street Analyst
★★★☆☆
#1032
on 13Foresight · ranked by our own returns
53%
Success Rate
-0.5%
Average Return
16 of 30 calls profitable · -3.9% vs benchmark
📈 Across the calls we could measure, roughly 53% of David S Macdonald's ratings turned a profit when each position was held for 1 year — averaging -0.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

146 Buy 87 Hold 0 Sell
David's Stock Coverage 31 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
PACS
PACS Group Inc
 Jun 15, 2026 BUY Strong Buy
+20.0% avg upside
9 analysts
$52.00
42.09% Upside
 ·
CNC
Centene
 Jun 01, 2026 BUY Buy
+8.7% avg upside
28 analysts
$71.00
16.33% Upside
 -2.2%
ELV
Elevance Health
 Jun 01, 2026 BUY Strong Buy
+10.8% avg upside
32 analysts
$450.00
15.84% Upside
 -3.1%
UNH
UnitedHealth
 Jun 01, 2026 BUY Strong Buy
+2.4% avg upside
35 analysts
$440.00
9.83% Upside
 +7.9%
HUM
Humana
 Jun 01, 2026 HOLD Buy
-11.2% avg upside
34 analysts
$320.00
11.30% Downside
 +10.3%
CVS
CVS Health
 Jun 01, 2026 BUY Strong Buy
+3.1% avg upside
38 analysts
$108.00
9.80% Upside
 +11.2%
HCA
HCA Healthcare
 May 28, 2026 BUY Buy
+14.2% avg upside
35 analysts
 — +1.2%
FMS
Fresenius Medical Care
 May 21, 2026 HOLD Buy
+97.5% avg upside
13 analysts
$26.00
10.18% Upside
 -5.0%
AVAH
Aveanna Healthcare Holdings
 May 20, 2026 HOLD Buy
+16.7% avg upside
17 analysts
$9.00
15.62% Upside
 -2.1%
RDNT
Radnet
 May 19, 2026 BUY Strong Buy
+50.1% avg upside
10 analysts
$90.00
67.56% Upside
 +5.9%
CON
Concentra Group Holdings Parent, Inc.
 May 11, 2026 BUY Strong Buy
+9.9% avg upside
9 analysts
$31.00
8.48% Upside
 +4.1%
MOH
Molina Healthcare
 May 11, 2026 HOLD Buy
+13.8% avg upside
25 analysts
$205.00
4.86% Upside
 +8.2%
PNTG
Pennant Group
 May 08, 2026 BUY Strong Buy
+5.8% avg upside
9 analysts
$42.00
25.68% Upside
 -11.7%
GRDN
Guardian Pharmacy Services, Inc. Class A
 May 08, 2026 BUY Strong Buy
-1.0% avg upside
7 analysts
$43.00
1.35% Upside
 +6.6%
DVA
DaVita
 May 08, 2026 HOLD Hold
-23.2% avg upside
17 analysts
$205.00
1.32% Downside
 +6.0%
ARDT
Ardent Health Partners, Inc.
 May 07, 2026 BUY Buy
+52.6% avg upside
16 analysts
$13.00
45.94% Upside
 -8.3%
AHCO
AdaptHealth
 May 06, 2026 BUY Strong Buy
+48.1% avg upside
12 analysts
$14.00
45.13% Upside
 -14.8%
MD
Pediatrix Medical Group
 May 06, 2026 HOLD Buy
-11.2% avg upside
14 analysts
$23.00
2.55% Downside
 +5.7%
CI
Cigna
 May 05, 2026 BUY Strong Buy
+23.8% avg upside
29 analysts
$350.00
25.32% Upside
 +4.5%
LH
Labcorp Holdings
 May 04, 2026 BUY Strong Buy
+1.8% avg upside
36 analysts
$320.00
25.03% Upside
 +1.4%
EHC
Encompass Health
 May 04, 2026 BUY Strong Buy
+13.4% avg upside
22 analysts
$140.00
42.91% Upside
 -8.2%
ENSG
The Ensign Group
 May 04, 2026 HOLD Strong Buy
+5.3% avg upside
9 analysts
$215.00
39.85% Upside
 -15.6%
THC
Tenet Healthcare
 May 04, 2026 BUY Strong Buy
+25.2% avg upside
26 analysts
$270.00
56.47% Upside
 -3.7%
OPCH
Option Care Health
 May 01, 2026 BUY Strong Buy
+34.9% avg upside
20 analysts
$30.00
36.44% Upside
 +8.4%
CYH
Community Health
 Apr 22, 2026 HOLD Sell
+44.8% avg upside
18 analysts
 — +4.1%
DGX
Quest Diagnostics
 Apr 22, 2026 HOLD Buy
-12.4% avg upside
33 analysts
 — -3.1%
SAIC
Science Applications
 Apr 03, 2023 HOLD Buy
+0.7% avg upside
20 analysts
$120.00
17.12% Upside
 +18.6%
PRVA
Privia Health Group
 Aug 12, 2022 BUY Strong Buy
+34.1% avg upside
26 analysts
$48.00
102.89% Upside
 -2.0%
AGL
Agilon Health
 Jul 14, 2022 BUY Buy
-59.1% avg upside
26 analysts
$33.00
70.94% Downside
 -35.7%
HCSG
Healthcare Services
 Oct 13, 2020 HOLD Buy
+5.8% avg upside
12 analysts
 — +1.5%
DE:FME
Fresenius Medical Care AG & Co. KGaA
 May 02, 2019 BUY Buy
+26.9% avg upside
21 analysts
$43.63
7.26% Upside
 ·
🔒 26 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David S Macdonald — Frequently Asked Questions
How accurate are David S Macdonald's stock ratings?
Based on the calls 13Foresight could measure, about 53% of David's ratings were profitable over a one-year hold, with an average return of -0.5% per rating, or -4.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is David ranked on 13Foresight?
David S Macdonald is currently ranked #1032 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on PACS, CNC, ELV, UNH, HUM, CVS, HCA, FMS, AVAH, RDNT, CON, MOH and 19 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.